SCYNEXIS
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SCYNEXIS and other ETFs, options, and stocks.About SCYX
SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J.
SCYX Key Statistics
Stock Snapshot
SCYNEXIS(SCYX) stock is priced at $5.00, giving the company a market capitalization of 49.75M. It carries a P/E multiple of -2.55.
As of 2026-09-11, SCYNEXIS(SCYX) stock has fluctuated between $4.88 and $5.06. The current price stands at $5.00, placing the stock +2.5% above today's low and -1.2% off the high.
SCYNEXIS(SCYX) shares are trading with a volume of 17.13K, against a daily average of 53.04K.
During the past year, SCYNEXIS(SCYX) stock moved between $3.53 at its lowest and $10.48 at its peak.
During the past year, SCYNEXIS(SCYX) stock moved between $3.53 at its lowest and $10.48 at its peak.
SCYX News
...
The latest update is out from SCYNEXIS ( (SCYX) ). On September 9, 2026, SCYNEXIS Chief Financial Officer Ivor Macleod retired from his roles as principal fina...
Scynexis (SCYX) announced the appointment of Sanjay Subramanian as CFO, effective September 9. The company also announced the retirement of Ivor Macleod from hi...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.